Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder
Conditions
Interventions
Escitalopram
Aripiprazole
+1 more
Locations
60
United States
Birmingham, Alabama, United States
Little Rock, Arkansas, United States
Carson, California, United States
Garden Grove, California, United States
Imperial, California, United States
Mission Viejo, California, United States
Start Date
July 29, 2010
Primary Completion Date
September 27, 2011
Completion Date
September 27, 2011
Last Updated
October 26, 2021
NCT07523048
NCT07226661
NCT06793397
NCT07025720
NCT07462013
NCT06804525
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions